Íæ²ÊÍø

½Ó´ýÀ´µ½Íæ²ÊÍø¼¯ÍŹÙÍø£¡

Ò½ÁÆÆ÷еȫÇò×¢²áЧÀÍ/ϵͳÈÏÖ¤/ÁÙ´²ÊÔÑéÊðÀí-Íæ²ÊÍø×Éѯ

רע ¡¤ רÐÄ ¡¤ רҵµÄÒ½ÁÆÆ÷е×Éѯ»ú¹¹

×ܹ«Ë¾

0755-27391220

¹ãÖݹ«Ë¾

020-82513196

¹ú¼Ê×¢²áЧÀÍ

ÄúµÄλÖãºÊ×ҳЧÀÍÏîÄ¿¹ú¼Ê×¢²áЧÀÍ

ÆäËû¹ú¼ÒÒ½ÁÆÆ÷еע²áÊðÀíЧÀÍ

°£¼°Ò½ÁÆÆ÷еע²áÊðÀíЧÀÍ£¬£¬ £¬£¬ £¬°¢ÂüÒ½ÁÆÆ÷еע²áÊðÀíЧÀÍ£¬£¬ £¬£¬ £¬¸çÂ×±ÈÑÇÒ½ÁÆÆ÷еע²áÊðÀíЧÀÍ£¬£¬ £¬£¬ £¬°¢¸ùÍ¢Ò½ÁÆÆ÷еע²áÊðÀíЧÀÍ£¬£¬ £¬£¬ £¬Ó¡¶ÈÒ½ÁÆÆ÷еע²áÊðÀíЧÀÍ£¬£¬ £¬£¬ £¬Ä«Î÷¸çÒ½ÁÆÆ÷еע²áÊðÀíЧÀÍ£¬£¬ £¬£¬ £¬ÐÂ¼ÓÆÂÒ½ÁÆÆ÷еע²áÊðÀíЧÀÍ£¬£¬ £¬£¬ £¬ÂíÀ´Î÷ÑÇÒ½ÁÆÆ÷еע²áÊðÀíЧÀÍ£¬£¬ £¬£¬ £¬Ì©¹úÒ½ÁÆÆ÷еע²áÊðÀíЧÀÍ£¬£¬ £¬£¬ £¬Ô½ÄÏÒ½ÁÆÆ÷еע²áÊðÀíЧÀÍ£¬£¬ £¬£¬ £¬ÎÚ¿ËÀ¼Ò½ÁÆÆ÷еע²áÊðÀíЧÀÍ£¬£¬ £¬£¬ £¬¶íÂÞ˹ҽÁÆÆ÷еע²áÊðÀíЧÀÍ£¬£¬ £¬£¬ £¬º«¹úÒ½ÁÆÆ÷еע²áÊðÀíЧÀÍ¡£¡£ ¡£¡£¡£
Éó²éÏêÇé Á¬Ã¦×Éѯ

°¢À­²®ÁªºÏÇõ³¤¹ú×¢²áÊðÀíЧÀÍ

°¢À­²®ÁªºÏÇõ³¤¹ú£¬£¬ £¬£¬ £¬¼ò³Æ°¢ÁªÇõ£¬£¬ £¬£¬ £¬Ê×¶¼ÔÚ°¢²¼Ôú±È£¬£¬ £¬£¬ £¬ÊÇÓëÉ³ÌØ°¢À­²®½»½ÓµÄ°¢À­²®¹ú¼Ò¡£¡£ ¡£¡£¡£ÔÚ°¢ÁªÇõ£¬£¬ £¬£¬ £¬Ò½ÁÆÆ÷еºÍÌåÍâÕï¶ÏÒ½ÁÆÆ÷е¶¼ÊÇÊܵ½°¢ÁªÇõÎÀÉú¾Ö£¨Ministry of Health and Prevention, ¼ò³ÆMOHAP£©ÏµÄÒ©Æ·¹Ü¿Ø²¿·ÖDrug Control Department¾ÙÐÐî¿Ïµ¡£¡£ ¡£¡£¡£
ÖµµÃ×¢ÖØµÄÊÇ£º¾³ÍâÆóÒµÔÚ°¢ÁªÇõÐèÒªÕÒµ½ÍâµØÕýµ±µÄÊðÀí£¨Agent£©À´¾ÙÐÐÒ½ÁÆÆ÷е·ÖÀàµÝ½»£¬£¬ £¬£¬ £¬×¢²áµÝ½»ÒÔ¼°ÓëMOHAP¾ÙÐÐÏàͬ¡£¡£ ¡£¡£¡£Í¬Ê±£¬£¬ £¬£¬ £¬ÍâµØ´ú±íÔÚ°¢ÁªÇõÉÐÓÐÒ»¸öºÜÊÇÖ÷ÒªµÄ½ÇɫҲÊDz»¿ÉÌæ»»µÄ£¬£¬ £¬£¬ £¬¾ÍÊÇÈë¿ÚÔÊÐíµÄÉêÇëÈË£¬£¬ £¬£¬ £¬Ö»ÓÐͨ¹ýÍâµØ´ú±í²Å»ª¾ÙÐвúÆ·»ñÖ¤ºóÈë¿ÚÔÊÐíµÄÉêÇëºÍ¿ª¾ß£¬£¬ £¬£¬ £¬ÄÇôҲ¾ÍÒâζ×ÅÄúµÄÍâµØ´ú±íÕÕ¾ÉÐèҪЭÖúÄúÍê³ÉºóÐøµÄÈë¿Ú»·½ÚµÄÊÂÒË¡£¡£ ¡£¡£¡£
Éó²éÏêÇé Á¬Ã¦×Éѯ

É³ÌØSFDA×¢²áÊðÀíЧÀÍ

É³ÌØÊ³ÎïºÍÒ©Æ·ÖÎÀí¾Ö(SFDA, The Saudi Food and Drug Authority)¡£¡£ ¡£¡£¡£ÈÏÕæî¿Ïµ¡¢¼àÊӺͼà²âʳÎï¡¢Ò©Æ·¡¢Ò½ÁÆÆ÷е£¬£¬ £¬£¬ £¬²¢Öƶ©Ç¿ÖÆÐÔ±ê×¼¹æ·¶£¬£¬ £¬£¬ £¬ÈÏÕæ SFDA »òÆäËû»ú¹¹ÊµÑéÊҵļà²âºÍ/»ò²âÊÔÔ˶¯µÄ»ú¹¹¡£¡£ ¡£¡£¡£±ðµÄ£¬£¬ £¬£¬ £¬SFDA»¹ÈÏÕæÏûºÄÕß¶ÔÓëʳÎï¡¢Ò©Æ·ºÍÒ½ÁÆÆ÷еÒÔ¼°ËùÓÐÆäËû²úÆ·ºÍÓÃÆ·ÓйصÄËùÓÐÊÂÏîµÄÈÏÖ¤¡£¡£ ¡£¡£¡£
É³ÌØÒ½ÁÆÆ÷е²¿·Ö£¨Medical Devices Sector£©ÔÚÖÜÈ«µÄÁ¢·¨ºÍî¿ÏµÏÂÈ·±£Ò½ÁÆÆ÷еµÄÇå¾²ÐÔ¡¢ÓÐÓÃÐÔºÍÐÔÄÜ·½ÃæÊ©Õ¹×ÅÒªº¦×÷Óᣡ£ ¡£¡£¡£É³ÌØÒ½ÁÆÆ÷еî¿Ïµ¿ò¼ÜÔÚЭЭµ÷Ç÷ͬ·½ÃæÓë¹ú¼ÊÀÏÀý¼á³ÖÒ»Ö£¬£¬ £¬£¬ £¬ËüÊÇÈ«ÇòЭµ÷ÊÂÇé×é (GHWP) µÄÖ÷ϯ£¬£¬ £¬£¬ £¬Ò²ÊÇ IMDRF ºÍ ISO ¶à¸öÊÖÒÕίԱ»áµÄÆð¾¢³ÉÔ±¡£¡£ ¡£¡£¡£
2019 Äê 12 Ô£¬£¬ £¬£¬ £¬É³Ìذ¢À­²®ÍƳöÁËеÄͳһµç×Óϵͳ¡°GHAD¡±£¬£¬ £¬£¬ £¬È¡´úÁËÏÖÓеÄÒ½ÁÆÆ÷еÉÏÊС¢×¢²áºÍÉèÁ¢ÔÊÐíϵͳ£¨MDMA¡¢MDNR ºÍ SFDA£©¡£¡£ ¡£¡£¡£×Ô 2021 Äê 7 ÔÂÆð£¬£¬ £¬£¬ £¬ÍâµØºÍÍâ¹úÒ½ÁÆÆ÷ÐµÖÆÔìÉÌÐèÒªÔÚÐÂϵͳ GHAD ÏÂ×¢²á»ò¸üÐÂÆäÔÊÐíÖ¤¡£¡£ ¡£¡£¡£
ÖµµÃ×¢ÖØµÄÊÇ£ºÔÚÉ³ÌØ¾ÙÐÐSFDA×¢²áǰÐèÒªÔÚÍâµØÈ·¶¨Ò»¸öÕýµ±µÄÊÚȨ´ú±í£¨AR£©£¬£¬ £¬£¬ £¬ÒÔ±ãÓëSFDA¾ÙÐÐ×¢²áÈÏÖ¤Ïàͬ¡£¡£ ¡£¡£¡£
Éó²éÏêÇé Á¬Ã¦×Éѯ

ÐÂÎ÷À¼Medsafe×¢²áÊðÀíЧÀÍ

ÐÂÎ÷À¼Medsafe£¨Medicines and Medical Devices Safety Authority£¬£¬ £¬£¬ £¬ÓÖ³ÆÒ©Æ·ºÍÒ½ÁÆÆ÷еÇå¾²ÖÎÀí¾Ö£©ÊÇÐÂÎ÷À¼Õþ¸®ÈÏÕæî¿ÏµºÍÖÎÀíÒ©Æ·¡¢Ò½ÁÆÆ÷еºÍÆäËûÒ½ÁƲúÆ·µÄ»ú¹¹¡£¡£ ¡£¡£¡£MedsafeÈÏÕæÆÀ¹ÀºÍÉóÅúÒ½ÁƲúÆ·µÄ×¢²á¡¢î¿ÏµÒ½ÁƲúÆ·µÄÖÊÁ¿¡¢Çå¾²ÐÔºÍÓÐÓÃÐÔ¡¢¼àÊÓÉú²úºÍÏúÊ۵ȡ£¡£ ¡£¡£¡£MedsafeµÄÖ÷ҪʹÃüÊÇÈ·±£ÐÂÎ÷À¼Êг¡ÉϵÄÒ½ÁƲúÆ·ÇкϹú¼ÒºÍ¹ú¼ÊµÄ±ê×¼ºÍÒªÇ󣬣¬ £¬£¬ £¬°ü¹Ü¹«ÖڵĿµ½¡ºÍÇå¾²¡£¡£ ¡£¡£¡£Îª´Ë£¬£¬ £¬£¬ £¬MedsafeÓëÆäËû¹ú¼ÊÒ½Ò©î¿Ïµ»ú¹¹¼á³ÖϸÃÜÏàÖú£¬£¬ £¬£¬ £¬ÅäºÏÔö½øÒ½ÁƲúÆ·µÄÇå¾²ºÍ¿É¿¿ÐÔ¡£¡£ ¡£¡£¡£
ÈçÒ½ÁÆÆ÷еÆóÒµ»ñµÃÁËÅ·ÃËCEÈÏÖ¤¡¢ÃÀ¹úFDA¡¢»ò¼ÓÄôóÎÀÉú²¿µÄMDL/MDEL×¢²áÈÏÖ¤£¬£¬ £¬£¬ £¬ÔòÔÚÐÂÎ÷À¼ÉÏÊкó30ÌìÄÚ£¨´Ó×°±¸Ê״εִïÐÂÎ÷À¼ÈÕÆÚ×îÏÈ£©ÐèÒªÍâµØÖ¸¶¨ÔÞÖúÉÌ£¨Sponsor£©½«ÄúµÄ²úÆ·ÁÐÈë MedSafe µÄWAND(Web Assisted Notification of Devices)Êý¾Ý¿â¡£¡£ ¡£¡£¡£
ÖµµÃ×¢ÖØµÄÊÇ£ºÐÂÎ÷À¼Ò²ÊÇÓÉÍâµØÖ¸¶¨ÔÞÖúÉÌ£¨Sponsor£©³ÖÖ¤£¬£¬ £¬£¬ £¬È«È¨ÈÏÕæ¾³ÍâÆóÒµÔÚÐÂÎ÷À¼ÍâµØµÄÆ÷еע²áÉÏÊУ¬£¬ £¬£¬ £¬¼ç¸ºÖ´·¨ÔðÈΣ»£»£»£» £»¶Ô WAND ÖÐÐÅÏ¢µÄ׼ȷÐÔÈÏÕæ£¬£¬ £¬£¬ £¬²¢ÇÒÊÇ Medsafe µÄΨһÁªÂçÈË¡£¡£ ¡£¡£¡£
Éó²éÏêÇé Á¬Ã¦×Éѯ

Ó¢¹úUKCA×¢²áÊðÀíЧÀÍ

Ó¢¹úÎÀÉúºÍÉç»á°ü¹Ü²¿£¨Department of Health and Social Care£©ÏÂϽҽÁƱ£½¡²úÆ·î¿Ïµ»ú¹¹£¨MHRA£¬£¬ £¬£¬ £¬Medical & Healthcare products Regulatory Agency£©¡£¡£ ¡£¡£¡£
¾³ÍâÆóÒµÈçÐ轫ҽÁÆÆ÷еÉÏÊе½Ó¢¹ú£¬£¬ £¬£¬ £¬×î¿ì½ÝµÄ·½·¨ÊÇʹÓÃÒÑÓеÄCE MDRÈÏÖ¤Ö¤Êé¾ÙÐÐת»»£»£»£»£» £»»òÕ߯¾Ö¤Ó¢¹úMHRAÓÚ2024Äê5ÔÂ21ÈÕÐû²¼µÄÄâÈϿɰĴóÀûÑÇ¡¢¼ÓÄôó¡¢Å·ÃË¡¢ÃÀ¹úÒ½ÁÆÆ÷еÈÏÖ¤µÄ²Ý°¸£¬£¬ £¬£¬ £¬ÔÚÄâÈϿɵÄÕâЩ¹ú¼Ò»ñµÃÒ½ÁÆÆ÷еÈÏÖ¤µÄÖ¤Êé»ò²¿±ðÀëÒÕÎļþ¾ÙÐÐת»»£»£»£»£» £»¸Ã²Ý°¸Ô¤¼Æ2025ÄêʵÑé¡£¡£ ¡£¡£¡£
ÖµµÃ×¢ÖØµÄÊÇ£ºa.¾³ÍâÆóÒµÒªµ½Ó¢¹ú¾³ÄÚÉêÇë×¢²á£¬£¬ £¬£¬ £¬ÐèÒªÓ¢¹úÊÚȨ´ú±í£¨UKRP£©£¬£¬ £¬£¬ £¬ÊÚȨ´ú±í½«Îª¾³ÍâÆóÒµÔÚÓ¢¹úÍÆÐÐÖ´·¨Ö°Ô𡣡£ ¡£¡£¡£b.ʹÓÃÆäËûÄâÈϿɹú¼ÒµÄÒ½ÁÆÆ÷еע²áÈÏÖ¤¾ÙÐÐת»»µÄ£¬£¬ £¬£¬ £¬Ó¢¹úMHRA½«²»»á½ÒÏþUKCAÈÏÖ¤±ê¼Ç¡£¡£ ¡£¡£¡£c.¾³ÍâÆóÒµÈ粻ʹÓÃÄâÈϿɹú¼ÒµÄÈÏÖ¤µ½Ó¢¹ú¾ÙÐÐת»»µÄ£¬£¬ £¬£¬ £¬ÔòÐèÒªÕÒÓ¢¹úMHRAÖ¸¶¨µÄµÚÈý·½×ÔÁ¦ÈÏÖ¤»ú¹¹AB ¡°Approved Body¡±¾ÙÐÐUKCAÈÏÖ¤ÉêÇë¡£¡£ ¡£¡£¡£d.±±°®¶ûÀ¼²»°üÀ¨ÔÚÓ¢¹úÒ½ÁÆÆ÷еî¿Ïµ¹æÔòÄÚ¡£¡£ ¡£¡£¡£
Éó²éÏêÇé Á¬Ã¦×Éѯ

ÈÕ±¾PMDA×¢²áÊðÀíЧÀÍ

Ò½ÁÆÆ÷еÆóҵϣÍû°Ñ²úƷͶ·Åµ½ÈÕ±¾Êг¡£¬£¬ £¬£¬ £¬±ØÐèÒªÖª×ãÈÕ±¾µÄ Pharmaceutical and Medical Device Act (PMD Act)¹æÔò¡£¡£ ¡£¡£¡£
ÈÕ±¾ºñÉúÀͶ¯Ê¡£¡£ ¡£¡£¡£¨MHLW£¬£¬ £¬£¬ £¬È«³ÆÎª¡°Ministry of Health, Labour and Welfare¡±£©ÏÂÊô²¿·Ö£ºÒ©Æ·ºÍÒ½ÁÆÆ÷е¾Ö (PMDA,È«³ÆÎª¡°Pharmaceuticals and Medical Devices Agency¡±)ÊÇÈÕ±¾µÄî¿Ïµ»ú¹¹¡£¡£ ¡£¡£¡£
Ò½ ÁÆ Æ÷ е ±Ø Ðë Òª ÓÉ Æä ÊÐ ³¡ Õýµ±ÊÚ È¨ ´ú±í MAH £¨ Marketing Authorization Holder £©Í¨¹ýÒÔϳÌÐòÈ¥×¢²áÆä²úÆ·¡£¡£ ¡£¡£¡£
Class I Æ÷е - ÉÏÊÐÌõ¼þ½» Todokede
IÀàÆ÷еÉÏÊÐǰ±ØÐèÓÉÆä MAH»ò DMAHÏò PMDA Ìá½»Ò»·ÝÉÏÊÐÌõ¼þ½»Îļþ£¬£¬ £¬£¬ £¬Õâ·ÝÎļþ²»ÐèÒª¾­ÓÉ PMDAµÄÉóºËºÍÅú×¼¡£¡£ ¡£¡£¡£
Class II Æ÷е - ÉÏÊÐǰÈÏÖ¤ Ninsho
×÷ÎªÌØÊâ¿ØÖÆµÄ II ÀàÆ÷еÉÏÊÐǰ±ØÐèÒª¾­ÓÉÉÏÊÐǰÈÏÖ¤¡£¡£ ¡£¡£¡£ÈÏÖ¤»ú¹¹£¨PCB£©Îª PMDA ÊÚȨ¿ÉÒÔ¾ÙÐÐ PMDAÈÏÖ¤µÄ»ú¹¹¡£¡£ ¡£¡£¡£
Class II£¬£¬ £¬£¬ £¬III,IV Æ÷е - ÉÏÊÐǰÅú×¼ Shonin
³ýÁËÌØÊâ¿ØÖÆµÄ II ÀàÆ÷еÍâµÄÆäËû II ÀàÆ÷еºÍ III,IV ÀàÆ÷е±ØÐèÒªÓÉÆä MAH »ò DMAH ÏñPMDAÌá½»ÉÏÊÐǰÅú×¼µÄÉêÇ룬£¬ £¬£¬ £¬²¢¾­ÓÉ PMDAÅú×¼ºó²Å»ª×¢²áËûÃǵIJúÆ·£¬£¬ £¬£¬ £¬²¢Í¶·ÅÊг¡¡£¡£ ¡£¡£¡£
ÖµµÃ×¢ÖØµÄÊÇ£º¾³ÍâµÄÒ½ÁÆÆ÷е½øÈëÈÕ±¾×¢²áʱֻÄÜÓÉÈÕ±¾ÊÚȨ´ú±í£¨MAH»òDMAH£©³ÖÖ¤£¬£¬ £¬£¬ £¬¾³ÍâµÄÒ½ÁÆÆ÷ÐµÖÆÔìÉÌÖ»»ñµÃ¡°Ò½ÁÆÆ÷еÍâ¹úÖÆÔìÒµÕßÉϰ¶Ö¤¡±£¨¼´ÏµÍ³Éó²é¼°¸ñÖ¤Ê飩¡£¡£ ¡£¡£¡£
Éó²éÏêÇé Á¬Ã¦×Éѯ

°ÍÎ÷ANVISA×¢²áÊðÀíЧÀÍ

°ÍÎ÷¹ú¼ÒÎÀÉúî¿Ïµ¾Ö£¨ANVISA£©ÈÏÕæî¿Ïµ°ÍÎ÷¾³ÄÚµÄÒ½ÁÆÆ÷еÔ˶¯¡£¡£ ¡£¡£¡£ÔÚ²úÆ·×¢²áÁ÷³Ì×îÏÈǰ£¬£¬ £¬£¬ £¬Ê×ÏÈÐèÒª¶Ô²úÆ·¾ÙÐзÖÀ࣬£¬ £¬£¬ £¬ANVISA½«²úÆ··ÖΪËÄÀ༴IÀà¡¢IIÀà¡¢IIIÀàºÍIVÀ࣬£¬ £¬£¬ £¬Î£º¦ÖÖ±ðÒ²ËæÖ®ÉÏÉý¡£¡£ ¡£¡£¡£ÎªÁ˼ò»¯µÍΣº¦ÖÖ±ðΣº¦Æ÷еµÄ×¢²áÁ÷³Ì£¬£¬ £¬£¬ £¬2022Äê9ÔÂANVISA¼ò»¯ÁËIÀàºÍIIÀàÒ½ÁÆÆ÷е²úÆ·µÄ×¢²áÁ÷³Ì£¬£¬ £¬£¬ £¬Ö®Ç°µÄ×¢²á·¾¶Cadastro±ä»»ÎªNotification¡£¡£ ¡£¡£¡£°ÍÎ÷µÄ²úÆ·×¢²á·ÖΪÁ½ÖÖ·¾¶NotificationºÍRegistro¡£¡£ ¡£¡£¡£Î£º¦¼¶±ð½ÏµÍµÄ²úÆ·£¨IÀà²úÆ·ºÍIIÀà²úÆ·£©µÄ×¢²á·¾¶ÎªNotification·¾¶£¬£¬ £¬£¬ £¬Î£º¦½Ï¸ßµÄ²úÆ·£¨IIIÀàºÍIVÀà²úÆ·£©¿ÉÒÔͨ¹ýRegistro·¾¶¾ÙÐÐ×¢²á¡£¡£ ¡£¡£¡£
ÏÖÐÐÒ½ÁÆÆ÷еî¿Ïµ¹æÔò£ºRDC 751-2022£¨2023Äê3ÔÂ1ÈÕÉúЧ£¬£¬ £¬£¬ £¬·ÏÖ¹ÁËÔ­¹æÔòRDC 185/2001£©
±ØÐèÇ¿µ÷µÄÊÇ£ºa.°ÍÎ÷Ö®ÍâµÄÍâÑóÆóÒµÈÏ֤ʱÐèÒªµ½°ÍÎ÷ÕÒÕýµ±µÄÊÚȨ´ú±í£¨°Í´úBRH£©,²¢ÇÒÖ»ÄÜÓɸÃÊÚȨ´ú±í³ÖÖ¤£»£»£»£» £»b.²úÆ·ÇкÏÒ½ÁÆÆ÷е¹æÔòÇÒ´øµçµÄ²úÆ·ÐèÒªÔÚÉêÇëǰ×öINMETROÈÏÖ¤£¬£¬ £¬£¬ £¬´øÀ¶ÑÀµÄÐèÒª×öANATELÈÏÖ¤£»£»£»£» £»c.²úÆ·µÄ×¢²áÉêÇë±í¡¢ËµÃ÷Êé¡¢±êÇ©±ØÐèÒÔÆÏÌÑÑÀÓïÌṩ£¬£¬ £¬£¬ £¬ÆäËûÊÖÒÕÎļþ¿ÉÒÔÊÇÆÏÌÑÑÀÓï¡¢Î÷°àÑÀÓï»òÕßÓ¢Óï¡£¡£ ¡£¡£¡£
Éó²éÏêÇé Á¬Ã¦×Éѯ

°Ä´óÀûÑÇTGA×¢²áÊðÀíЧÀÍ

°Ä´óÀûÑÇTGA×¢²á£¬£¬ £¬£¬ £¬TGA ÊÇ Therapeutic Goods Administration µÄ¼òд£¬£¬ £¬£¬ £¬È«³ÆÊÇÖÎÁÆÉÌÆ·ÖÎÀí¾Ö£¬£¬ £¬£¬ £¬ËüÊǰĴóÀûÑǵÄÖÎÁÆÉÌÆ·£¨°üÀ¨Ò©Îï¡¢Ò½ÁÆÆ÷е¡¢»ùÒò¿Æ¼¼ºÍÑªÒºÖÆÆ·£©µÄ¼àÊÓ»ú¹¹¡£¡£ ¡£¡£¡£TGA ¿ªÕ¹Ò»ÏµÁÐµÄÆÀÉóºÍ¼àÊÓÖÎÀíÊÂÇ飬£¬ £¬£¬ £¬ÒÔÈ·±£ÔÚ°Ä´óÀûÑÇÌṩµÄÖÎÁÆÉÌÆ·ÇкÏÊÊÓõıê×¼£¬£¬ £¬£¬ £¬²¢°ü¹Ü°Ä´óÀûÑÇÉç»áµÄÖÎÁÆË®Æ½ÔÚÒ»¸ö½Ï¶ÌµÄʱ¼äÄÚµÖ´ï½Ï¸ßµÄˮƽ¡£¡£ ¡£¡£¡£
¹ÜÖÆµÄ¿ò¼ÜÊÇÒÔÈ·¶¨¹«ÖڵĿµ½¡ºÍÇå¾²ÖÎÀíΪ»ù´¡Éè¼ÆµÄ, ͬʱҲ¼õÇáÆóÒµÈκβ»ÐëÒªµÄ¹ÜÖÆ¼ç¸º¡£¡£ ¡£¡£¡£ÊÂʵÉÏ£¬£¬ £¬£¬ £¬¹ÜÖÆÒªÇó¶ÔÈκβúÆ·½øÈë°Ä´óÀûÑÇÉú²ú»òÏúÊÛǰ£¬£¬ £¬£¬ £¬±ØÐèÏÈͨ¹ý¡°°Ä´óÀûÑÇ×î¼ÑÖÎÁÆ·¨°¸¹ÒºÅ¡± Australian register of therapeutic goods (ARTG)¡£¡£ ¡£¡£¡£ARTG ÊǾ­Åú×¼²úÆ·ÒѾ­ÇкÏÈËÌåÇå¾²ÐèÒªµÄÅÌËã»úÊý¾Ý¿â¡£¡£ ¡£¡£¡£
Éó²éÏêÇé Á¬Ã¦×Éѯ
×Éѯ

µç»°

×ܹ«Ë¾

0755-27391220

¹ãÖÝÈÈÏß

020-82513196

΢ÐÅ

¶þάÂë

΢Ðſͷþ

¶þάÂë

С³ÌÐò

ÓÊÏä

ÆóÒµÓÊÏä

www.reanny@reanny.com

¡¾ÍøÕ¾µØÍ¼¡¿